货号:GS40809
Zalifrelimab (AGEN-1884) is an investigational human immunoglobulin G1 (IgG1) monoclonal antibody that targets cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Developed as an immune checkpoint inhibitor, it aims to enhance anti-tumor immune responses and has been evaluated primarily in clinical trials for advanced solid tumors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物